Syneos Health, Inc. - (SYNH): Price and Financial Metrics

Syneos Health, Inc. - (SYNH)

Today's Latest Price: $75.42 USD

0.39 (-0.51%)

Updated Jan 15 4:00pm

Add SYNH to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 64 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

SYNH Stock Summary

  • Syneos Health Inc's market capitalization of $7,884,020,757 is ahead of 79.59% of US-listed equities.
  • SYNH's went public 6.19 years ago, making it older than merely 21.95% of listed US stocks we're tracking.
  • The volatility of Syneos Health Inc's share price is greater than that of just 15.92% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Syneos Health Inc are FWONA, CLGX, MTZ, CATM, and WRK.
  • SYNH's SEC filings can be seen here. And to visit Syneos Health Inc's official web site, go to

SYNH Stock Price Chart Interactive Chart >

Price chart for SYNH

SYNH Price/Volume Stats

Current price $75.42 52-week high $76.84
Prev. close $75.81 52-week low $30.02
Day low $74.83 Volume 620,200
Day high $76.84 Avg. volume 694,960
50-day MA $66.64 Dividend yield N/A
200-day MA $59.39 Market Cap 7.84B

Syneos Health, Inc. - (SYNH) Company Bio

Syneos Health, formerly INC Research Holdings, provide the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The company was founded in 2010 and is based in Raleigh, North Carolina.

SYNH Latest News Stream

Event/Time News Detail
Loading, please wait...

SYNH Latest Social Stream

Loading social stream, please wait...

View Full SYNH Social Stream

Latest SYNH News From Around the Web

Below are the latest news stories about Syneos Health Inc that investors may wish to consider to help them evaluate SYNH as an investment opportunity.

Syneos Health provides FY 2021 guidance

Syneos Health ([[SYNH]] +0.3%) provides FY 2021 outlook in Form 8-K filing.Company expects revenue to be in the range of $5.125B-5.325B, growth rate 16.3-20.9%.Adjusted EBITDA $745B-785B, growth rate 18.3-24.6%.Adjusted EBITDA margin of 14.5-14.7%.Adjusted diluted EPS $4.09-4.38, growth rate 20.6-29.2%.Details of strategic partnership over the past few quarters:The company is targeting...

Seeking Alpha | January 13, 2021

Have Insiders Been Buying Syneos Health, Inc. (NASDAQ:SYNH) Shares?

It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...

Yahoo | January 13, 2021

Why It Might Be Time To Pay Attention To These 3 Red-Hot Health Stocks

The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.

Yahoo | January 7, 2021

Are These Medical Stocks Cruising Toward Bullish Gains? Here's A Key Sign

Medical stocks made a comeback in 2020. The best-performing among them include medical technology companies with high Composite Ratings, a key metric measuring growth.

Yahoo | January 7, 2021

Syneos Health to Present at the 39th Annual J.P. Morgan Healthcare Conference

MORRISVILLE, N.C., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced that Chief Executive Officer Alistair Macdonald is scheduled to present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021, at 8:20 a.m. EST. A live webcast of the event, along with a link to the presentation materials and archived audio replay of the presentation, will be available on the Company’s Investor Relations website at Syneos Health Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract R...

Yahoo | January 4, 2021

Read More 'SYNH' Stories Here

SYNH Price Returns

1-mo 9.23%
3-mo 26.33%
6-mo 23.80%
1-year 17.86%
3-year 89.50%
5-year 75.89%
YTD 10.70%
2020 14.55%
2019 51.14%
2018 -9.75%
2017 -17.11%
2016 8.43%

Continue Researching SYNH

Want to see what other sources are saying about Syneos Health Inc's financials and stock price? Try the links below:

Syneos Health Inc (SYNH) Stock Price | Nasdaq
Syneos Health Inc (SYNH) Stock Quote, History and News - Yahoo Finance
Syneos Health Inc (SYNH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8368 seconds.